← FDA Drug Approvals (Drugs@FDA)

BIAXIN XL

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2000-03-03

Drug application

FDA Application #

NDA050775

Application type

New Drug Application

Brand name

BIAXIN XL

Generic name

Clarithromycin

Active ingredients

CLARITHROMYCIN

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2000-03-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown